Cargando…

Preclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertility

BACKGROUND: TEX101 is a cell membrane protein exclusively expressed by testicular germ cells and shed into seminal plasma. We previously verified human TEX101 as a biomarker for the differential diagnosis of azoospermia, and developed a first-of-its-kind TEX101 ELISA. To demonstrate the clinical uti...

Descripción completa

Detalles Bibliográficos
Autores principales: Korbakis, Dimitrios, Schiza, Christina, Brinc, Davor, Soosaipillai, Antoninus, Karakosta, Theano D., Légaré, Christine, Sullivan, Robert, Mullen, Brendan, Jarvi, Keith, Diamandis, Eleftherios P., Drabovich, Andrei P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363040/
https://www.ncbi.nlm.nih.gov/pubmed/28330469
http://dx.doi.org/10.1186/s12916-017-0817-5
_version_ 1782517095192330240
author Korbakis, Dimitrios
Schiza, Christina
Brinc, Davor
Soosaipillai, Antoninus
Karakosta, Theano D.
Légaré, Christine
Sullivan, Robert
Mullen, Brendan
Jarvi, Keith
Diamandis, Eleftherios P.
Drabovich, Andrei P.
author_facet Korbakis, Dimitrios
Schiza, Christina
Brinc, Davor
Soosaipillai, Antoninus
Karakosta, Theano D.
Légaré, Christine
Sullivan, Robert
Mullen, Brendan
Jarvi, Keith
Diamandis, Eleftherios P.
Drabovich, Andrei P.
author_sort Korbakis, Dimitrios
collection PubMed
description BACKGROUND: TEX101 is a cell membrane protein exclusively expressed by testicular germ cells and shed into seminal plasma. We previously verified human TEX101 as a biomarker for the differential diagnosis of azoospermia, and developed a first-of-its-kind TEX101 ELISA. To demonstrate the clinical utility of TEX101, in this work we aimed at evaluating ELISA performance in a large population of fertile, subfertile, and infertile men. METHODS: Mass spectrometry, size-exclusion chromatography, ultracentrifugation, and immunohistochemistry were used to characterize TEX101 protein as an analyte in seminal plasma. Using the optimized protocol for seminal plasma pretreatment, TEX101 was measured by ELISA in 805 seminal plasma samples. RESULTS: We demonstrated that TEX101 was present in seminal plasma mostly in a free soluble form and that its small fraction was associated with seminal microvesicles. TEX101 median values were estimated in healthy, fertile pre-vasectomy men (5436 ng/mL, N = 64) and in patients with unexplained infertility (4967 ng/mL, N = 277), oligospermia (450 ng/mL, N = 270), and azoospermia (0.5 ng/mL, N = 137). Fertile post-vasectomy men (N = 57) and patients with Sertoli cell-only syndrome (N = 13) and obstructive azoospermia (N = 36) had undetectable levels of TEX101 (≤0.5 ng/mL). A cut-off value of 0.9 ng/mL provided 100% sensitivity at 100% specificity for distinguishing pre- and post-vasectomy men. The combination of a concentration of TEX101 > 0.9 ng/mL and epididymis-specific protein ECM1 > 2.3 μg/mL provided 81% sensitivity at 100% specificity for differentiating between non-obstructive and obstructive azoospermia, thus eliminating the majority of diagnostic testicular biopsies. In addition, a cut-off value of ≥0.6 ng/mL provided 73% sensitivity at 64% specificity for predicting sperm or spermatid retrieval in patients with non-obstructive azoospermia. CONCLUSIONS: We demonstrated the clinical utility of TEX101 ELISA as a test to evaluate vasectomy success, to stratify azoospermia forms, and to better select patients for sperm retrieval. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-017-0817-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5363040
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53630402017-03-24 Preclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertility Korbakis, Dimitrios Schiza, Christina Brinc, Davor Soosaipillai, Antoninus Karakosta, Theano D. Légaré, Christine Sullivan, Robert Mullen, Brendan Jarvi, Keith Diamandis, Eleftherios P. Drabovich, Andrei P. BMC Med Research Article BACKGROUND: TEX101 is a cell membrane protein exclusively expressed by testicular germ cells and shed into seminal plasma. We previously verified human TEX101 as a biomarker for the differential diagnosis of azoospermia, and developed a first-of-its-kind TEX101 ELISA. To demonstrate the clinical utility of TEX101, in this work we aimed at evaluating ELISA performance in a large population of fertile, subfertile, and infertile men. METHODS: Mass spectrometry, size-exclusion chromatography, ultracentrifugation, and immunohistochemistry were used to characterize TEX101 protein as an analyte in seminal plasma. Using the optimized protocol for seminal plasma pretreatment, TEX101 was measured by ELISA in 805 seminal plasma samples. RESULTS: We demonstrated that TEX101 was present in seminal plasma mostly in a free soluble form and that its small fraction was associated with seminal microvesicles. TEX101 median values were estimated in healthy, fertile pre-vasectomy men (5436 ng/mL, N = 64) and in patients with unexplained infertility (4967 ng/mL, N = 277), oligospermia (450 ng/mL, N = 270), and azoospermia (0.5 ng/mL, N = 137). Fertile post-vasectomy men (N = 57) and patients with Sertoli cell-only syndrome (N = 13) and obstructive azoospermia (N = 36) had undetectable levels of TEX101 (≤0.5 ng/mL). A cut-off value of 0.9 ng/mL provided 100% sensitivity at 100% specificity for distinguishing pre- and post-vasectomy men. The combination of a concentration of TEX101 > 0.9 ng/mL and epididymis-specific protein ECM1 > 2.3 μg/mL provided 81% sensitivity at 100% specificity for differentiating between non-obstructive and obstructive azoospermia, thus eliminating the majority of diagnostic testicular biopsies. In addition, a cut-off value of ≥0.6 ng/mL provided 73% sensitivity at 64% specificity for predicting sperm or spermatid retrieval in patients with non-obstructive azoospermia. CONCLUSIONS: We demonstrated the clinical utility of TEX101 ELISA as a test to evaluate vasectomy success, to stratify azoospermia forms, and to better select patients for sperm retrieval. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-017-0817-5) contains supplementary material, which is available to authorized users. BioMed Central 2017-03-23 /pmc/articles/PMC5363040/ /pubmed/28330469 http://dx.doi.org/10.1186/s12916-017-0817-5 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Korbakis, Dimitrios
Schiza, Christina
Brinc, Davor
Soosaipillai, Antoninus
Karakosta, Theano D.
Légaré, Christine
Sullivan, Robert
Mullen, Brendan
Jarvi, Keith
Diamandis, Eleftherios P.
Drabovich, Andrei P.
Preclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertility
title Preclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertility
title_full Preclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertility
title_fullStr Preclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertility
title_full_unstemmed Preclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertility
title_short Preclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertility
title_sort preclinical evaluation of a tex101 protein elisa test for the differential diagnosis of male infertility
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363040/
https://www.ncbi.nlm.nih.gov/pubmed/28330469
http://dx.doi.org/10.1186/s12916-017-0817-5
work_keys_str_mv AT korbakisdimitrios preclinicalevaluationofatex101proteinelisatestforthedifferentialdiagnosisofmaleinfertility
AT schizachristina preclinicalevaluationofatex101proteinelisatestforthedifferentialdiagnosisofmaleinfertility
AT brincdavor preclinicalevaluationofatex101proteinelisatestforthedifferentialdiagnosisofmaleinfertility
AT soosaipillaiantoninus preclinicalevaluationofatex101proteinelisatestforthedifferentialdiagnosisofmaleinfertility
AT karakostatheanod preclinicalevaluationofatex101proteinelisatestforthedifferentialdiagnosisofmaleinfertility
AT legarechristine preclinicalevaluationofatex101proteinelisatestforthedifferentialdiagnosisofmaleinfertility
AT sullivanrobert preclinicalevaluationofatex101proteinelisatestforthedifferentialdiagnosisofmaleinfertility
AT mullenbrendan preclinicalevaluationofatex101proteinelisatestforthedifferentialdiagnosisofmaleinfertility
AT jarvikeith preclinicalevaluationofatex101proteinelisatestforthedifferentialdiagnosisofmaleinfertility
AT diamandiseleftheriosp preclinicalevaluationofatex101proteinelisatestforthedifferentialdiagnosisofmaleinfertility
AT drabovichandreip preclinicalevaluationofatex101proteinelisatestforthedifferentialdiagnosisofmaleinfertility